Low-Throughput Molecular Diagnostic Testing Landscape Assessment
Clinical Diagnostics
66
250
>15
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation
Objective
A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market
Our Approach
Secondary Research
- Performed a benchmark analysis of all major LT MDx competitors, profiling multiple attributes (e.g., turnaround time, throughput, current menu, future menu, key features) for each LT MDx platform
Primary Research
- Conducted 66 in-depth stakeholder interviews with lab directors from MDx labs in multiple settings and of varying throughputs in 20 different countries
- Conducted a ~250 person survey and choice-task conjoint analysis of lab directors from labs of varying throughput and organization type from 15 different countries
Quantitative Analysis
- Built comprehensive, bottom-up and top-down models of the LT MDx market segmented by geography, lab throughput, therapeutic area, lab type, test regulatory status, and platform technology
- Conducted a conjoint choice-task analysis to assess ideal instrument features (6 attributes, 17 levels), with results segmented by respondent geography and lab throughput
- Built a dynamic NPV model using the output of the conjoint analysis to estimate the potential market share captured and NPV of developing an instrument with any combination of features explored in the conjoint
Outcome
- DeciBio identified different customer behaviors, and strategies that the client should pursue in the LT MDx market in different geographies
- DeciBio specified which instrument features should be prioritized in future platform development efforts in order to capture LT market share
- DeciBio identified gaps in the client's portfolio that should be addressed to target a potentially disruptive segment of the LT MDx market
Related Client Results
Genetic Testing Company Assessment
Target Identification
RWD Biobank Offering Go-to-Market Strategy
Voice-of-Customer Research
Go-to-Market Strategy
Pricing Strategy
Competitive Analysis
Infectious Pathogen Diagnostics Technology Commercialization
Voice-of-Customer Research